2月21日 - ** 基因疗法生产商蓝鸟生物BLUE.O股价盘前下跌38.6%至4.32美元
** 公司称将被凯雷CG.O和SK Capital Partners私有化 (link)
** BLUE 股东将获得每小时 3 美元的现金，这意味着股权价值约为 2920 万美元。
** 与该股上次收盘价 7.04 美元相比，该报价折价超过 57
** 投资公司还提出了每小时 6.84 美元的额外报价，条件是达到某些销售里程碑，这意味着需要支付约 6650 万美元。
** BLUE 在 2024 年下跌了 69.8
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.